Skip to main content

European Vaccination Beyond Covid (EUVABECO)

Project/agreement No.
101132545
Project funding
8 444 996.40 EUR, including ERDF funding of 80% or 6.755,996.95 EUR, of which RSU ERDF funding is 356.491.46 EUR.
Project manager
Project realization
01.01.2024. - 30.06.2026.

Aim

The EUVABECO project aims to provide the Member States of the European Union (EU) with evidence-informed and validated implementation plans for key vaccination practices so as to allow Member States to reproduce the conditions for the deployment of said practices or other similar ones that would be relevant for routine vaccination or a future crisis, across borders and in different geographies and jurisdictions.

Description

The COVID-19 crisis has transformed vaccination practices across the world, with hundreds of innovative practices that would have otherwise only emerged years later. These practices are usually developed and generally anchored to the frameworks of their country of origin, i.e., with a rather specific legal, technical, organizational, ethical, and economic context that has allowed their emergence and implementation. 

Preparatory groundwork allowed the EUVABECO Consortium to select five such key tools, for which a baseline version has already been implemented during the COVID-19 crisis. These will be utilised so as to elaborate, test, amend and validate the plans allowing any Member State to successfully proceed to implementation. 

The selected tools are: 

  1. A clinical decision system, providing justified recommendations for vaccination; 
  2. A screening tool to identify reach and invite vulnerable populations; 
  3. The electronic patient leaflet, allowing to transfer vaccines across countries without need to repackage them; 
  4. A modelling and forecasting tool to assess the impact of public health interventions; 
  5. A portable digital vaccination card to ensure lifelong traceability and continuity of care. 

The plans will be tested through twelve (12) pilot projects, to be executed from September 2024 until August 2025 in seven (7) EU Member States, i.e., Belgium, Germany, Greece, Latvia, Luxembourg, Poland and Portugal. The outcomes of these pilot projects will then be assessed against a set of reference vaccination practices for a delivery of the finalized plans to Member States in 2026. 

Coordinator

University of Crete (GR)

Partners

  • Luxembourg eHealth Agency (LU)
  • Cimbiose (FR)
  • Portugal Health General Directorate (PT)
  • FRATEM (BE)
  • Jagellonian University (PL)
  • Linköping University (SE)
  • Rīga Stradiņš University (LV)
  • Sciensano (BE)
  • Syadem (FR)
  • University of Crete (GR)
  • University of Thessaly (GR)
  • University of Saarland (DE)
  • Vaccines Europe (BE)
  • Wroclaw Medical University (PL). 

Official website of the project:  Home page - EUVABECO 

 

Media releases

RSU gets involved in European Union project to adopt new vaccination practices

 

Co-funded by the European Union. Grant agreement No. 101132545.